Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIK in Cardiac Surgery
NCT01516138Phase 2Unknown
- Sponsor
- Xijing Hospital
- Start
- Feb 2012
- Primary completion
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium potassium magnesium calcium and glucose injection, human insulin and potassium chloride in Myocardial injury (2 arms), sponsored by Xijing Hospital. Primary endpoint: Major Adverse Cardiac Events. Status: unknown.
02
Drugs
sodium potassium magnesium calcium and glucose injectionhuman insulinpotassium chloride
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on NCT01516138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516138.